Literature DB >> 6273499

Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.

H J Field, E De Clercq.   

Abstract

Mice infected with herpes simplex virus (HSV) were treated (separately) with the nucleoside analogues acyclovir or bromovinyldeoxyuridine by incorporating the drugs in the drinking water. This method of treatment was found to be effective for both drugs and compared favourably with intraperitoneal injection. Prompt treatment with either compound could prevent the establishment of latent infections but latent infections once established were intractable using prolonged courses of oral administration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273499     DOI: 10.1099/0022-1317-56-2-259

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.

Authors:  W G Liu; Z J Chen; J Z Song; Z X Ma
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

3.  Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

4.  Effect of recombinant mouse interferon-beta on acute and latent herpes simplex infection in mice.

Authors:  M Yamada; Y Arao; A Hatano; F Uno; S Nii
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  A novel oral vehicle for poorly soluble HSV-helicase inhibitors: PK/PD validations.

Authors:  Jianmin Duan; Francine Liard; William Paris; Michelle Lambert
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

6.  Viral forensic genomics reveals the relatedness of classic herpes simplex virus strains KOS, KOS63, and KOS79.

Authors:  Christopher D Bowen; Daniel W Renner; Jacob T Shreve; Yolanda Tafuri; Kimberly M Payne; Richard D Dix; Paul R Kinchington; Derek Gatherer; Moriah L Szpara
Journal:  Virology       Date:  2016-03-21       Impact factor: 3.616

Review 7.  Antiherpes drugs: promises and pitfalls.

Authors:  E de Clercq
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

8.  A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections.

Authors:  A Wald; J Benedetti; G Davis; M Remington; C Winter; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.

Authors:  A M Thackray; H J Field
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy.

Authors:  H J Field
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.